Adult domiciliary oxygen therapy. Position statement of the Thoracic Society of Australia and New Zealand

Med J Aust. 1998 Jan 5;168(1):21-5. doi: 10.5694/j.1326-5377.1998.tb123340.x.


Evidence shows that patients with chronic obstructive pulmonary disease and a stable daytime PaO2 of 55 mm Hg or less will have longer life expectancy if given supplemental oxygen to keep the PaO2 above 60 mm Hg, preferably for longer than 15 hours a day, including sleep. There is some evidence for improved quality of life. It is reasonable to offer this therapy for other lung diseases which cause chronic hypoxaemia, and there are also less well defined indications for supplemental oxygen during exercise, sleep and air travel.

Publication types

  • Guideline

MeSH terms

  • Adult
  • Aged
  • Australia
  • Home Care Services*
  • Humans
  • Lung Diseases, Obstructive / therapy
  • Middle Aged
  • Patient Selection
  • Respiration, Artificial*